Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastro Oesophageal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00004127
What this trial is testing

Oxaliplatin Combined With Fluorouracil and Leucovorin in Treating Patients With Recurrent or Metastatic Cancer of the Esophagus or Stomach

Who this might be right for
Esophageal CancerGastric Cancer
University of Chicago 35
Not applicableStudy completedNCT02722785
What this trial is testing

PeRioperative Study of Exercise Training in Patients With Operable Cancer of the Gastroesophageal Junction

Who this might be right for
Gastro-esophageal Cancer
Jesper Frank Christensen, PhD 40
Not applicableStudy completedNCT03388047
What this trial is testing

Feasibility of Multi-Spectral Endoscopic Imaging for Detection of Early Neoplasia in Barrett's Oesophagus

Who this might be right for
Barrett EsophagusEsophageal NeoplasmsReflux Esophagitis
University of Cambridge 20
Not applicableLooking for participantsNCT06033976
What this trial is testing

Endoscopic Submucosal Dissection Registry

Who this might be right for
Neoplasm, StomachNeoplasm, ColorectalNeoplasm, Esophagus+1 more
Carol Davila University of Medicine and Pharmacy 200
Not applicableLooking for participantsNCT05514769
What this trial is testing

Proximal Gastrectomy Anterior Anastomosis With Pyloroplasty Versus Esophagogastric Anastomosis for Gastric Cancer

Who this might be right for
Proximal Gastric AdenocarcinomaGastric CancerGastroesophageal Reflux Disease
Nanchong Central Hospital 60
Testing effectiveness (Phase 2)Study completedNCT04426669
What this trial is testing

Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering

Who this might be right for
Gastrointestinal Epithelial CancerGastrointestinal NeoplasmsCancer of Gastrointestinal Tract+8 more
Intima Bioscience, Inc. 23
Not applicableStudy completedNCT04526886
What this trial is testing

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

Who this might be right for
Colorectal CancerGastric CancerEsophageal Cancer+3 more
Dartmouth-Hitchcock Medical Center 52
Testing effectiveness (Phase 2)UnknownNCT03789617
What this trial is testing

A Multi-center, Single-arm, Open, Phase I/IIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell (EBV Specific Autologous CD8+ T Cell) in Patients With Treatment Failed Epstein Barr Virus (EBV)-Positive Malignancies

Who this might be right for
EBV Associated Extranodal NK/T-cell LymphomaEBV-Associated GastricCarcinoma or Esophageal AdenoCarcinoma
Eutilex 72
Not applicableStudy completedNCT02731313
What this trial is testing

Human Epidermal Growth Factor Receptor 2 (HER-2) Status in Gastric and Gastro-Esophageal Junction (GEJ) Carcinoma

Who this might be right for
Gastric Cancer, Gastroesophageal Junction Cancer
Hoffmann-La Roche 420
Large-scale testing (Phase 3)UnknownNCT02773524
What this trial is testing

Regorafenib in Refractory Advanced Gastro-Oesophageal Cancer

Who this might be right for
Gastro-Oesophageal Cancer
Australasian Gastro-Intestinal Trials Group 250
Testing effectiveness (Phase 2)UnknownNCT01795768
What this trial is testing

Proof-of-Concept Study of AZD4547 in Patients With FGFR1 or FGFR2 Amplified Tumours

Who this might be right for
Gastric CancerOesophageal CancerBreast Cancer+1 more
Royal Marsden NHS Foundation Trust 48
Early research (Phase 1)Ended earlyNCT04171141
What this trial is testing

Study to Test the Safety and Tolerability of PF-07062119 in Patients With Selected Advanced or Metastatic Gastrointestinal Tumors.

Who this might be right for
Gastrointestinal TumorsColorectal AdenocarcinomasGastric Adenocarcinomas+1 more
Pfizer 79
Early research (Phase 1)Looking for participantsNCT07179692
What this trial is testing

CEA-Targeted CAR-T Therapy in CEA-Positive Advanced Solid Tumors

Who this might be right for
Lung CancerGastric CancerColon Cancer+3 more
Chongqing Precision Biotech Co., Ltd 108
Very early researchLooking for participantsNCT06824363
What this trial is testing

ProofPrincip IntraTu TCells SinglDoseImmunCheckpoinInhib Gastro-Esophage Adenocarcinoma w/ARID1a Mu

Who this might be right for
Solid Tumor, AdultMalignant Solid TumorStomach Adenocarcinoma+1 more
University of California, Irvine 34
Not applicableStudy completedNCT03706846
What this trial is testing

Study of Two Fasting Procedures Before Gastroscopy: 6 Hours Versus 2 Hours for Clear Fluids

Who this might be right for
Cirrhosis
Centre Hospitalier Universitaire de Besancon 70
Testing effectiveness (Phase 2)UnknownNCT03957564
What this trial is testing

Liquid Biopsy in Monitoring the Neoadjuvant Chemotherapy and Operation in Gastric Cancer

Who this might be right for
Gastric CancerGastro-oesophageal Junction Cancer
Affiliated Hospital of Qinghai University 40
Testing effectiveness (Phase 2)Ended earlyNCT02999893
What this trial is testing

APR-246 in Oesophageal Cancer

Who this might be right for
Oesophageal Carcinoma
Peter MacCallum Cancer Centre, Australia 5
Not applicableLooking for participantsNCT06995898
What this trial is testing

The Vanguard Study: Testing a New Way to Screen for Cancer

Who this might be right for
Bladder CarcinomaBreast CarcinomaColorectal Carcinoma+8 more
National Cancer Institute (NCI) 24,000
Early research (Phase 1)WithdrawnNCT02598687
What this trial is testing

Testing TH-302, in Combination With Preoperative Chemoradiotherapy, in Esophageal Cancer.

Who this might be right for
Esophageal Cancer
Maastricht Radiation Oncology
Early research (Phase 1)Ended earlyNCT01705340
What this trial is testing

Akt Inhibitor MK2206, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With Locally Advanced or Metastatic HER2-Positive Breast , Gastric, or Gastroesophageal Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionHER2-positive Breast CancerMale Breast Cancer+9 more
National Cancer Institute (NCI) 60
Next Page